Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Venture
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

iCo Therapeutics Inc

+ Add to Watchlist

ICO:CN

0.0850 CAD 0.0050 5.56%

As of 15:55:01 ET on 04/24/2015.

Snapshot for iCo Therapeutics Inc (ICO)

Open: 0.1000 Day's Range: 0.0750 - 0.1000 Volume: 4,907,361
Previous Close: 0.0900 52wk Range: 0.0250 - 0.3700 1-Yr Rtn: -76.39%

Stock Chart for ICO

No chart data available.
  • ICO:CN 0.0850
  • 1D
  • 1M
  • 1Y
0.0900
Interactive ICO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ICO

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPTSX -
Earnings Per Share (CAD) (ttm) -0.4040
Est. EPS (CAD) (12/2015) -
Est. PEG Ratio -
Market Cap (M CAD) 7.18
Shares Outstanding (M) 84.46
30 Day Average Volume 2,457,443
Price/Book (mrq) 1.1285
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ICO

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for ICO

ICO Therapeutics Inc. is a biotechnology company focused on redosing or reformulating drugs with clinical history for new or expanded indications. The Company's products in development include a treatment for Diabetic Macular Edema and a treatment for severe ocular allergies.

Andrew J RaePresident/CEOJohn William MeekisonCFO/Co-Founder
Peter HnikChief Medical Officer
More Company Profile & Key Executives for ICO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil